Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wejstal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|April 12, 1986
Liver damage associated with fansidarR Wejstal, J Lindberg, B E Malmvall, et al.
Journal of Viral Hepatitis|December 15, 2000
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirinT Carlsson, K Lindahl, R Schvarcz, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Activated Cellular Immunity in Chronic Hepatitis CA Diez-Ruiz, G Norkrans, R Wejstal, et al.
The European Journal of Medicine|July 1, 1992
Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2bD Fuchs, G Norkrans, R Wejstal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|April 12, 1986
Liver damage associated with fansidarR Wejstal, J Lindberg, B E Malmvall, et al.
Journal of Viral Hepatitis|December 15, 2000
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirinT Carlsson, K Lindahl, R Schvarcz, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Activated Cellular Immunity in Chronic Hepatitis CA Diez-Ruiz, G Norkrans, R Wejstal, et al.
The European Journal of Medicine|July 1, 1992
Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2bD Fuchs, G Norkrans, R Wejstal, et al.
Pageof 1